Sign in

CIK 0001674416

  • Large accelerated filer

CRISPR Therapeutics AG

Sign in to watch
Ticker
CRSP
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Switzerland
Entity type
Operating
EIN
473173478
Phone
+1 617-315-4600
Business address
BAARERSTRASSE 14, ZUG, Switzerland
Former names
CRISPR Therapeutics AG
  1. 4 Open-market sale Director sold 35,473 shares at an average $18.63 ($660,888)
  2. 4 Open-market sale Chief Legal Officer sold 15,000 shares at an average $18.57 ($278,479)
  3. 4 Open-market sale Director sold 50,477 shares at an average $17.81 ($899,216)
  4. 4 Derivatives Options or other derivatives
  5. 4 Open-market sale Director sold 5,512 shares at an average $17.51 ($96,491)
  6. 3 Insider Initial Statement of Ownership
  7. 4 Open-market sale Director sold 41,312 shares at an average $17.63 ($728,134)
  8. 4 Open-market sale Director sold 32,930 shares at an average $17.60 ($579,545)
  9. 4 Open-market sale Director sold 69,859 shares at an average $16.84 ($1,176,710)
  10. 4 Open-market sale Director sold 31,992 shares at an average $16.56 ($529,938)
  11. 4 Open-market sale Director sold 4,254 shares at $16.26 ($69,170)
  12. 4 Open-market sale Director sold 43,202 shares at an average $16.90 ($730,125)
  13. 4 Open-market sale Director sold 81,435 shares at an average $17.08 ($1,390,611)
  14. 4 Open-market sale Director sold 32,368 shares at an average $16.23 ($525,302)
  15. 4 Open-market sale Chief Executive Officer sold 10,825 shares at $15.37 ($166,388)
  16. 4 Open-market sale Chief Executive Officer sold 30,222 shares at an average $15.01 ($453,511)
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Open-market sale Chief Executive Officer sold 5,303 shares at an average $15.02 ($79,628)

Page 22 of 26 · 502 filings